Variant report
Variant | esv3398393 |
---|---|
Chromosome Location | chr6:92058939-92103471 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:79)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr6:92094246-92094496 | HepG2 | liver: | n/a | chr6:92094368-92094381 chr6:92094368-92094381 chr6:92094348-92094361 chr6:92094368-92094381 chr6:92094369-92094380 |
2 | CEBPB | chr6:92062565-92062924 | Hela-S3 | cervix: | n/a | chr6:92062741-92062754 chr6:92062741-92062754 |
3 | CEBPB | chr6:92093364-92093602 | IMR90 | lung: | n/a | chr6:92093458-92093471 |
4 | CEBPB | chr6:92062590-92062900 | IMR90 | lung: | n/a | chr6:92062741-92062754 chr6:92062741-92062754 |
5 | CTCF | chr6:92097460-92097610 | HBMEC | blood vessel: | n/a | n/a |
6 | CTCF | chr6:92097520-92097670 | NB4 | blood: | n/a | n/a |
7 | CTCF | chr6:92097480-92097684 | HepG2 | liver: | n/a | n/a |
8 | CTCF | chr6:92097537-92097646 | MCF-7 | breast: | n/a | n/a |
9 | CTCF | chr6:92060748-92060801 | Medullo | brain: | n/a | n/a |
10 | CTCF | chr6:92097500-92097650 | GM12869 | blood: | n/a | n/a |
11 | CTCF | chr6:92097620-92097770 | MCF-7 | breast: | n/a | n/a |
12 | CTCF | chr6:92097417-92097714 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | CTCF | chr6:92097499-92097609 | SK-N-SH_RA | brain: | n/a | n/a |
14 | CTCF | chr6:92097480-92097630 | GM12865 | blood: | n/a | n/a |
15 | CTCF | chr6:92097340-92097490 | GM06990 | blood: | n/a | n/a |
16 | CTCF | chr6:92097521-92097606 | MCF-7 | breast: | n/a | n/a |
17 | CTCF | chr6:92097520-92097670 | HEK293 | kidney: | n/a | n/a |
18 | CTCF | chr6:92097540-92097674 | HepG2 | liver: | n/a | n/a |
19 | CTCF | chr6:92097420-92097570 | RPTEC | kidney: | n/a | n/a |
20 | CTCF | chr6:92097451-92097696 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | CTCF | chr6:92097687-92097704 | IMR90 | lung: | n/a | n/a |
22 | CTCF | chr6:92097540-92097690 | WERI-Rb-1 | eye: | n/a | n/a |
23 | CTCF | chr6:92097500-92097650 | RPTEC | kidney: | n/a | n/a |
24 | CTCF | chr6:92097518-92097633 | MCF-7 | breast: | n/a | n/a |
25 | CTCF | chr6:92097520-92097670 | HepG2 | liver: | n/a | n/a |
26 | CTCF | chr6:92090036-92090063 | Lung_OC | lung: | n/a | n/a |
27 | CTCF | chr6:92097540-92097690 | GM12872 | blood: | n/a | n/a |
28 | CTCF | chr6:92097371-92097802 | H1-hESC | embryonic stem cell: | n/a | n/a |
29 | CTCF | chr6:92097440-92097590 | GM12872 | blood: | n/a | n/a |
30 | EBF1 | chr6:92095688-92095888 | GM12878 | blood: | n/a | chr6:92095833-92095844 |
31 | ELF1 | chr6:92086231-92086712 | MCF-7 | breast: | n/a | n/a |
32 | ELF1 | chr6:92086481-92086762 | GM12878 | blood: | n/a | n/a |
33 | FOS | chr6:92062655-92062882 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | FOS | chr6:92061311-92061481 | MCF10A-Er-Src | breast: | n/a | chr6:92061359-92061368 chr6:92061359-92061366 |
35 | FOS | chr6:92062682-92062810 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | FOS | chr6:92062585-92062799 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | FOS | chr6:92061219-92061419 | MCF10A-Er-Src | breast: | n/a | chr6:92061359-92061368 chr6:92061359-92061366 |
38 | FOS | chr6:92061293-92061494 | MCF10A-Er-Src | breast: | n/a | chr6:92061359-92061368 chr6:92061359-92061366 |
39 | GATA3 | chr6:92091254-92091839 | MCF-7 | breast: | n/a | n/a |
40 | GATA3 | chr6:92091228-92091545 | MCF-7 | breast: | n/a | n/a |
41 | JUND | chr6:92092045-92092049 | H1-hESC | embryonic stem cell: | n/a | n/a |
42 | MAFF | chr6:92067060-92067330 | HepG2 | liver: | n/a | chr6:92067184-92067202 |
43 | MAFF | chr6:92093034-92093281 | HepG2 | liver: | n/a | chr6:92093104-92093122 |
44 | MAFF | chr6:92085785-92086008 | HepG2 | liver: | n/a | chr6:92085903-92085921 |
45 | MAFF | chr6:92070055-92070178 | HepG2 | liver: | n/a | n/a |
46 | MAFK | chr6:92095286-92095361 | HepG2 | liver: | n/a | chr6:92095306-92095321 |
47 | MAFK | chr6:92070110-92070124 | HepG2 | liver: | n/a | n/a |
48 | MAFK | chr6:92092961-92093271 | IMR90 | lung: | n/a | chr6:92093106-92093121 |
49 | MAFK | chr6:92092967-92093281 | HepG2 | liver: | n/a | chr6:92093106-92093121 |
50 | MAFK | chr6:92067019-92067326 | HepG2 | liver: | n/a | chr6:92067189-92067200 chr6:92067190-92067201 chr6:92067189-92067200 chr6:92067190-92067201 chr6:92067185-92067200 chr6:92067185-92067201 chr6:92067188-92067202 |
No data |
(count:2 , 50 per page) page:
1
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MAP3K7-1 | chr6:92101922-92102045 | XLOC_005782 |
2 | lnc-MAP3K7-1 | chr6:92102633-92102718 | XLOC_005782 |
3 | lnc-MAP3K7-1 | chr6:92100031-92100262 | XLOC_005782 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000224605 | TF binding region |
ENSG00000222894 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374822647 | chr6:92061456-92061457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs191950984 | chr6:92061467-92061468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571290454 | chr6:92061476-92061477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368946747 | chr6:92061488-92061489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147926027 | chr6:92061527-92061528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs78999122 | chr6:92061538-92061539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573955356 | chr6:92061616-92061617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543309841 | chr6:92061700-92061701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs9353824 | chr6:92061701-92061702 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs544542343 | chr6:92061748-92061749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147120457 | chr6:92061749-92061750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369726354 | chr6:92061790-92061791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543959774 | chr6:92061808-92061809 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs564200433 | chr6:92061823-92061824 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532956151 | chr6:92061843-92061844 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148155105 | chr6:92061853-92061854 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540270425 | chr6:92061882-92061883 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560197581 | chr6:92061889-92061890 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529152615 | chr6:92061903-92061904 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549278480 | chr6:92061904-92061905 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184419937 | chr6:92061932-92061933 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189493755 | chr6:92061933-92061934 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs34029037 | chr6:92061962-92061963 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551561125 | chr6:92061963-92061964 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571448803 | chr6:92061966-92061967 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534038741 | chr6:92062041-92062042 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553704236 | chr6:92062058-92062059 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs58565535 | chr6:92062130-92062131 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536513726 | chr6:92062150-92062151 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7768509 | chr6:92062172-92062173 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576541166 | chr6:92062174-92062175 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs140719716 | chr6:92062190-92062191 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192986601 | chr6:92062229-92062230 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564342140 | chr6:92062239-92062240 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs577769879 | chr6:92062275-92062276 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540331655 | chr6:92062276-92062277 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs560160517 | chr6:92062281-92062282 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs184314652 | chr6:92062344-92062345 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542542252 | chr6:92062365-92062366 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs562828198 | chr6:92062369-92062370 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531401542 | chr6:92062391-92062392 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532079160 | chr6:92062536-92062537 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551122930 | chr6:92062577-92062578 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs532655765 | chr6:92062578-92062579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6911257 | chr6:92062606-92062607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs113199726 | chr6:92062635-92062636 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527753091 | chr6:92062674-92062675 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547501314 | chr6:92062677-92062678 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7749168 | chr6:92062706-92062707 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs569122606 | chr6:92062730-92062731 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 19490664 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neuropathy | 19664229 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:92061400-92062800 | Enhancers | Fetal Lung | lung |
2 | chr6:92061600-92061800 | Enhancers | Fetal Stomach | stomach |
3 | chr6:92061800-92064200 | Weak transcription | Fetal Stomach | stomach |
4 | chr6:92062600-92063000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr6:92064200-92065000 | Enhancers | Fetal Stomach | stomach |
6 | chr6:92084200-92086800 | Enhancers | Stomach Mucosa | stomach |
7 | chr6:92084400-92085000 | Enhancers | Duodenum Mucosa | Duodenum |
8 | chr6:92084600-92084800 | Enhancers | Gastric | stomach |
9 | chr6:92085000-92085800 | Weak transcription | Duodenum Mucosa | Duodenum |
10 | chr6:92085000-92086200 | Weak transcription | Gastric | stomach |
11 | chr6:92085800-92086600 | Enhancers | Duodenum Mucosa | Duodenum |
12 | chr6:92086200-92086800 | Enhancers | Gastric | stomach |
13 | chr6:92086400-92087200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr6:92086600-92087000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr6:92086600-92087000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr6:92087200-92088600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
17 | chr6:92088800-92089000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr6:92088800-92089400 | Enhancers | Brain Germinal Matrix | brain |
19 | chr6:92095400-92095600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
20 | chr6:92095800-92096800 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
21 | chr6:92096800-92097800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
22 | chr6:92097000-92097600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |